News & Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
PUBLICATION
Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
PUBLICATION
Standardized Behavioral Test Battery to Identify and Validate Targets for Neuropsychiatric Diseases and Pain.
PUBLICATION
Genetic disruption of both tryptophan hydroxylase genes strongly reduces serotonin in the brain and affects behavior in models sensitive to antidepressants
PUBLICATION
Netrin-G2 and netrin-G2 ligand are both required for normal auditory responsiveness.
PUBLICATION
Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice.
PUBLICATION
New methodological aspects of microdialysis.
PUBLICATION
Continuous delivery of rotigotine decreases extracellular dopamine suggesting continuous receptor stimulation.
PUBLICATION
Measurement of brain microglial proliferation rates in vivo in response to neuroinflammatory stimuli: application to drug discovery.
PUBLICATION
